Trial intelligence / Profile preview

Oxytocin and Dyadic Psychotherapy in Postpartum Depression

NCT02191423Unknown

Sponsor
Tel Aviv Sourasky Medical Center
Start
Jan 2015
Primary completion
Jun 2016
Modality
Peptides
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin in postpartum depression (PPD) (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoints: Effect of the administration of oxytocin on cerebral circuit processing at 2 weeks, Interactional measures-CIB at 11 weeks and 1 more. Status: unknown.

02

Drugs

oxytocin
03

Conditions

postpartum depression (PPD)

Beyond the preview

Go deeper on NCT02191423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02191423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call